Midline Restoration After HYbriD Hernia RepAir Surgery (HYDRA) (HYDRA)

February 22, 2024 updated by: Prof. dr. Pieter J Tanis, Erasmus Medical Center

Midline Restoration After HYbriD Incisional Hernia RepAir (HYDRA) With the SymbotexTM Mesh

The goal of this observational study is to learn about the functioning of the abdominal wall in patients who underwent hybrid (open- and laparoscopic) incisional hernia repair. The main objective is to assess the anatomical restoration and function of the linea alba one year after surgery by ultrasonography and mean peak torque during trunk flexion using a BioDex machine.

Study Overview

Status

Not yet recruiting

Intervention / Treatment

Detailed Description

Rationale: Abdominal wall functioning has been reported to be higher in patients that underwent open incisional hernia repair compared to laparoscopic incisional hernia repair. With the use of a recently developed hybrid approach, we aim for a functional anatomical restoration of the linea alba while also achieving the technical advantages of the hybrid approach.

Objective: The main objective is to asses functional anatomical restoration of the linea alba through functioning in mean peak torque, and ultrasound examination.

Study design: Multicentre prospective cohort study. Study population: Adult patients with a midline incisional hernia ≥4 cm and ≤10 cm.

Intervention: Not applicable. Main study parameters/endpoints: The primary objective of this study is to assess anatomical restoration and function of the linea alba one year after surgery by ultrasonography and measuring the mean peak torque during trunk flexion using a BioDex(trademark) machine.

Nature and extent of the burden and risks associated with participation, benefit and group relatedness: No risk is associated with participation other than known complications for incisional hernia repair. HYDRA is part of standard care in the Alrijne Hospital, and the technique has previously been published. The mesh used in this study is being used on a world-wide scale. We do not expect additional risks with this study. As participants have to visit the Erasmus Medical Center (Erasmus MC) an additional three times and have to fill in additional questionnaires, there is a burden for enrolled patients.

Study Type

Observational

Enrollment (Estimated)

52

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Leiden, Netherlands
        • Alrijne Hospital
        • Contact:
          • Willem Hueting, MSc

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

N/A

Sampling Method

Non-Probability Sample

Study Population

Patients scheduled for Hybrid repair of their incisional hernia

Description

Inclusion Criteria:

  • 18 years or older
  • Scheduled for elective HYDRA-surgery
  • Midline incisional hernia larger than 4 centimetres in mean width
  • Sufficient knowledge of the Dutch language to be able to understand and fill in the questionnaires
  • Signed informed consent form by patient

Exclusion Criteria:

  • Pregnant at inclusion
  • Inclusion in other trials with interference of the primary and secondary endpoints
  • American Society of Anesthesiologists Classification (ASA Classification) > 3
  • Hernia defect larger than 10 centimetres in mean width
  • Incarcerated hernias or emergency procedure
  • Unable to perform a trunk flexion
  • Incapacitated patients

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Incisional Hernia patients
Patients with an Incisional Hernia, who present in the participating center
Hybrid incisional hernia repair, as described by Van den Dop et al. (2021)
Other Names:
  • three-step incisional hybrid repair (TIHR)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mean peak torque 1 year
Time Frame: 12 months
The functioning of the abdominal wall in Nm/kg as assessed by a BioDex
12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mean peak torque 2 years
Time Frame: 24 months
The functioning of the abdominal wall in Nm/kg as assessed by a BioDex
24 months
Recurrent Incisional Hernia
Time Frame: 1 month, 12 months and 24 months
Ultrasonography examination of the abdominal wall for the detection of a recurrent incisional hernia.
1 month, 12 months and 24 months
Severity of surgical complications
Time Frame: 1 month
Through Clavien-Dindo classification
1 month
Surgical complications
Time Frame: 1 month
Type of complication will be recorded as a free-text field
1 month
General Quality of Life
Time Frame: pre-operative, 12 months and 24 months
Measure quality of life using the Short Form Health Survey, a 36-question questionnaire
pre-operative, 12 months and 24 months
Mesh specific Quality of Life
Time Frame: 1 month, 12 months and 24 months
The Carolina Comfort Scale, which is a mesh-specific quality of life questionnaire, will be used in order to assess satisfaction with the placed mesh.
1 month, 12 months and 24 months
Scar satisfaction
Time Frame: pre-operative, 1 day, 1 month
Visual Analogue Scale for the how satisfied patients are with the new scar from the surgery, reaching from 0 to 10.
pre-operative, 1 day, 1 month
Pain in the abdominal region
Time Frame: pre-operative, 1 day, 1 month
Visual Analogue Scale for pain in the region of the hernia reaching from 0 to 10.
pre-operative, 1 day, 1 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Pieter Tanis, Prof. dr., Erasmus Medical Center

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

April 1, 2024

Primary Completion (Estimated)

April 1, 2027

Study Completion (Estimated)

April 1, 2028

Study Registration Dates

First Submitted

December 15, 2023

First Submitted That Met QC Criteria

February 22, 2024

First Posted (Estimated)

February 29, 2024

Study Record Updates

Last Update Posted (Estimated)

February 29, 2024

Last Update Submitted That Met QC Criteria

February 22, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

The data is partly retrieved from patient files and from questionnaires (after informed consent). Even though the data is pseudonymized, there is too much risk of confidentiality breach.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Incisional Hernia of Midline of Abdomen

Clinical Trials on Hybrid Surgery

3
Subscribe